DIN 02271249 — ERBITUX 2 MG
ERBITUX is a solution of Cetuximab marketed by IMCLONE, LLC. The full Cetuximab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02271249
- Brand name
- ERBITUX
- Active ingredient
- Cetuximab
- Strength
- 2 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- IMCLONE, LLC
- Health Canada status
- MARKETED
- Drug class
- Epidermal growth factor receptor (EGFR) inhibitor monoclonal antibody
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.